Abstract | AIM: PATIENTS AND METHODS: RESULTS: Specific clinical factors, including tumor size, histopathology of biopsy sample, and tumor morphology, were significantly correlated with peritoneal metastasis. CA19-9, lymphocyte count and NLR were also predictive factors for peritoneal metastasis. Multivariate analysis identified the clinical factors tumor morphology and histopathology, and laboratory markers CA19-9 and lymphocyte count as independent factors predictive for peritoneal metastasis. A combination of independent predictive factors achieved high predictive accuracy (0.882) for peritoneal metastasis preoperatively. CONCLUSION: A combination of specific factors is an alternative method to preoperatively discriminate patients with GC with peritoneal metastasis from those without.
|
Authors | Masaki Ohi, Koichiro Mori, Yuji Toiyama, Yasuhiko Mohri, Masato Okigami, Hiromi Yasuda, Susumu Saigusa, Koji Tanaka, Yasuhiro Inoue, Masato Kusunoki |
Journal | Anticancer research
(Anticancer Res)
Vol. 35
Issue 6
Pg. 3511-8
(Jun 2015)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 26026118
(Publication Type: Journal Article)
|
Copyright | Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Chemical References |
- Biomarkers, Tumor
- CA-19-9 Antigen
- Carcinoembryonic Antigen
- Serum Albumin
- C-Reactive Protein
|
Topics |
- Adult
- Aged
- Biomarkers, Tumor
(blood)
- C-Reactive Protein
(metabolism)
- CA-19-9 Antigen
(blood)
- Carcinoembryonic Antigen
(blood)
- Female
- Humans
- Lymphocyte Count
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Metastasis
- Peritoneal Neoplasms
(blood, pathology, secondary)
- Preoperative Period
- Prognosis
- Serum Albumin
(genetics)
- Stomach Neoplasms
(blood, drug therapy, pathology)
|